$BSGM “Ultimate Stock Alerts” BioSig Technologies, Inc. Newsletter 7:32:35 AM February 20, 2020

on February 20, 2020 Newsletters and Tags: , , , , , , , , , , with 0 comments

Overall Perfomance for "Ultimate Stock Alerts"

The following three charts can be used by potential investors to gauge the performance of "Ultimate Stock Alerts":


0 out of 1 campaigns closed down on first day


1 out of 1 campaigns closed up on first day


0 out of 1 campaigns had no net effect

BSGM Promotional Newsletter

The following is a newsletter released by "Ultimate Stock Alerts" promoting BioSig Technologies, Inc.


The following newsletter has not been verified for accuracy or completeness.


Don't Want Anymore Emails


Today, we would like to bring to your attention a new trade opportunity.

This little known company could be positioned for incredible growth.

Trade Idea BioSig Technologies, Inc. NASDAQ BSGM

Technology is changing the way we receive healthcare.

Bioelectronic medicine is a new approach to treating and diagnosing disease and injury.

This new field uses device technology to read and modulate the electrical activity within the bodys nervous system, opening new doors to real-time diagnostics and treatment options for patients.

One of the exciting aspects of bioelectronic medicine is its potential to supplement and even replace drugs, including their cost and often debilitating side effects.

This is benefiting not only patients, but also companies and investors.

Bioelectronic medicine could deliver treatment breakthroughs for many diseases that currently have a high level of unmet need.

BSGM, our new trade opportunity, could be positioned for significant growth in this growing industry.

BSGM is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology EP marketplace.

By providing clearer biomedical signals, the companys advanced signal processing capabilities can help clinicians to better understand patterns and how to change them to treat, or even prevent, diseases.

The companys goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia.

BSGMs PURE EPTM System is a computerized system engineered to assist electrophysiologists in clinical decision-making during electrophysiology procedures in patients with abnormal heart rates and rhythms.

But this technology could present an even larger market opportunity for the company.

As the company states on its website

In an article in The Journal of Innovations in Cardiac Rhythm Management, electrophysiology researchers noted that signal recording and processing is an integral part of various mapping techniques in fields other than cardiology.

We hope to apply the expanded hardware configurations of the PURE EP system for mapping and recording signals in fields like neurology and ophthalmology, in order to better be able to characterize regional electrical activity.

Led by a proven management team and a veteran Board of Directors, BioSig Technologies is preparing to commercialize its PURE EPTM System.

Already, BioSig has partnered with Minnetronix on technology development and received FDA 510k clearance for the PURE EPTM System in August 2018.

The Company initiated its first clinical trial in November 2019, and is currently enrolling patients at Texas Cardiac Arrhythmia Institute at St. Davids Medical Center and Mayo Clinics Florida campus.

Earlier in 2019 the Company conducted patient cases at Indiana University School of Medicine, Greenville Memorial Hospital, Santa Barbara Cottage Hospital and Texas Cardiac Arrhythmia Institute at St. Davids Medical Center.

The Companys PURE EPtm System was used during the procedures on patients with persistent atrial fibrillation, ischemic ventricular tachycardias, PVC, atypical flutters and other types of complex arrhythmias.

BSGM has announced numerous developments recently that highlight the companys many potentially significant accomplishments.

In November, the company announced BioSig Technologies Signs Three New Licensing Agreements with Mayo Clinic

Here are the highlights from this press release

New areas of collaboration identified between Mayo Clinic and BioSig
Focus on previously untapped arrhythmia treatments
Additional development areas covering novel therapies for autonomic nervous system disease

In January the company announced BioSig Awarded Additional US Patent Claims for its PURE EPTM System

As the company stated in the press release

The allowed patent application complements BioSigs expanding patent portfolio, which now includes five allowedissued patents. Eleven additional worldwide utility patent applications are pending covering various aspects of its PURE EPTM System for recording, measuring, calculating and displaying of electrocardiograms during cardiac ablation procedures. BioSig also has 21 allowedissued worldwide design patents, which cover various features of its display screens and graphical user interface for enhanced visualization of biomedical signals.

In addition, in January, the company announced BioSig to Commence Patient Cases at Mayo Clinic

But, thats not all

Yesterday, the company announced BioSig Completes 100th Patient Case with PURE EPTM System

BSGM could be an overlooked trade opportunity capable of providing increased growth.

Make sure to do your own due diligence.

Sources , , , , , , , , , ,

Happy Trading


Note We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term trade opportunities.

Trading Rules Please Review Before Taking Any Action

Do not invest more than you are willing to lose. No one likes to consider the worst case, but its always a risk that exists. Rule of thumb - if you cannot sleep at night as a consequence of your investment, then you have over invested.
Keep calm. Do not chase. Decide for yourself if you like the trade. If you are not comfortable with the perceived risks, stay out. Timelines are to be decided by you. Approach methodically, and seek technical confirmation for direction. Always trade with a strategy in mind.
Never use market orders. Only use buy and sell limit orders. Protecting your investment is more important than missing gains. Use trailing stop % or trailing stop $ orders. Personally I prefer mental stops while actively managing trades rather than entering your stop into your brokerage account.
Cut losses quickly when dayswing trading. It's better to acknowledge being wrong than to have false hope. Sometimes you will be wrong in doing so, often times it will save you. It all depends on your entry.
Actively manage all your investments trade during market hours only. Trading during prepost market hours carries greater volatilityrisk.



This reportrelease is a commercial advertisement and is for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for compensation. Never invest in any stock featured on our reportsreleases unless you can afford to lose your entire investment. The track record, gains, upside or losses are all hypothetical and should not be considered as a basis for investment. While we do not charge for the SMS service, standard carrier message and data rates may apply.

This reportrelease is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the States or other jurisdictions in which the security is eligible for sale. Reportsreleases distributed through disseminated reportsreleased are not disclosure documents. If you are considering purchasing any securities of an advertised company, you should read and review, if and to the extent available, any information concerning a marketed company available at the web sites of the U.S. Securities and Exchange Commission the SEC at www.sec.govthe Financial Industry Regulatory Authority the FINRA at www.FINRA.org and your State Securities Administrator. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.govconsumercyberfr.htm, as well as related information published by the FINRA on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence.

You agree and acknowledge that any hyperlinks to the website of 1 a client company, 2 the party issuing or preparing the information for the company, or 3 other information contained in our disseminated reportsreleases is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of these external sites, nor are we responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated reportrelease or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated reportrelease or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any company mentioned herein.

We have not determined if the statements and opinions of the message are accurate, correct or truthful. The profiles we publish are compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because virtually all information relied upon by us in preparing an Issuer profile comes from a public source which has been made public directly from the Issuer, the information is not confirmed with a second source.

The purpose of this reportrelease, like any promotion, is to provide publicity for the client company, its products or services. Owners and operators of UltimateStockAlerts.com have been compensated twenty thousand dollars cash via bank wire, earned upon receipt, for the distribution of our opinions and publicly available information for BSGM by Venado Media on 21420. Previously, owners and operators of UltimateStockAlerts.com have been compensated ten thousand three hundred dollars cash via bank wire, earned upon receipt, for the distribution of our opinions and publicly available information for BSGM by TSX Ventures LLC on 102617. Previously, owners and operators of UltimateStockAlerts.com have been compensated ten thousand dollars cash, via bank wire, earned upon receipt, for distribution of our opinions and publicly available information for BSGM from Sunrise Media LLC on 12717. Owners and operators of UltimateStockAlerts.com hold no stocks or bonds in mentioned companies as of 22020. You should not rely on the information presented you should do independent research to form your own opinion and decision. Information contained in our disseminated reportsreleases does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment. Owners and operators of UltimateStockAlerts.com own several newsletters, therefore you may receive our emails featuring companies at different times.

You are receiving this reportrelease because you subscribed to received it at our website or through a third party site. All of our newsletters include an unsubscribe link, and you can remove yourself at any time from our newsletters by clicking on that unsubscribe link. You can also contact us at infoultimatestockalerts.com to change your information at any time. By your subscription to our profiles, the viewing of this profile andor use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be read at any time at www.UltimateStockAlerts.comDisclaimer and www.UltimateStockAlerts.comPrivacy-Policy

The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions quote may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.

Our records indicate that . requested and confirmed to be added to UltimateStockAlerts.com on January 26, 2015.

6020 Bent Pine Dr, Orlando, FL 32822, USA